{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:46:14Z","timestamp":1787010374256,"version":"build-2736575974"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To generate a prediction model for the selection of treatment modality for early-stage non\u2013small cell lung cancer (NSCLC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Stereotactic body radiotherapy (SBRT) and minimally invasive surgery (MIS) are used in the local treatment of early-stage NSCLC. However, the selection of patients for either SBRT or MIS remains challenging due to the multitude of factors influencing the decision-making process.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We analyzed 1291 patients with clinical stage I NSCLC treated with intended MIS or SBRT from January 2020 to July 2023. A prediction model for selection for SBRT was created based on multivariable logistic regression analysis. The receiver operating characteristic curve analysis stratified the cohort into 3 treatment-related risk categories. Postprocedural outcomes, recurrence, and overall survival (OS) were investigated to assess the model's performance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      In total, 1116 patients underwent MIS and 175 SBRT. The prediction model included age, performance status, previous pulmonary resection, MSK-Frailty score, FEV1 and DLCO, and demonstrated an area-under-the-curve of 0.908 (95% CI: 0.876\u20130.938). Based on the probability scores (n=1197), patients were stratified into a low-risk (MIS, n=970 and SBRT, n=28), intermediate-risk (MIS, n=96 and SBRT, n=53), and high-risk category (MIS, n=10 and SBRT, n=40). Treatment modality was not associated with OS [HR of SBRT, 1.67 (95% CI: 0.80\u20133.48);\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.20].\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Clinical expertise can be translated into a robust predictive model, guiding the selection of stage I NSCLC patients for MIS versus SBRT and effectively categorizing them into 3 distinct risk groups. Patients in the intermediate category could benefit most from multidisciplinary evaluation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/sla.0000000000006552","type":"journal-article","created":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T05:01:47Z","timestamp":1727758907000},"page":"807-816","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Real-world Decision-making Process for Stereotactic Body Radiotherapy Versus Minimally Invasive Surgery in Early-stage Lung Cancer Patients"],"prefix":"10.1097","volume":"283","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8432-1685","authenticated-orcid":false,"given":"Stijn","family":"Vanstraelen","sequence":"first","affiliation":[{"name":"Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9757-1325","authenticated-orcid":false,"given":"Kay See","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1699-2046","authenticated-orcid":false,"given":"Prasad S.","family":"Adusumilli","sequence":"additional","affiliation":[{"name":"Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5406-0784","authenticated-orcid":false,"given":"Manjit S.","family":"Bains","sequence":"additional","affiliation":[{"name":"Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0523-4028","authenticated-orcid":false,"given":"Matthew J.","family":"Bott","sequence":"additional","affiliation":[{"name":"Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Downey","sequence":"additional","affiliation":[{"name":"Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Gomez","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine D.","family":"Gray","sequence":"additional","affiliation":[{"name":"Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Huang","sequence":"additional","affiliation":[{"name":"Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7305-876X","authenticated-orcid":false,"given":"James M.","family":"Isbell","sequence":"additional","affiliation":[{"name":"Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1655-4473","authenticated-orcid":false,"given":"Daniela","family":"Molena","sequence":"additional","affiliation":[{"name":"Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3814-5144","authenticated-orcid":false,"given":"Bernard J.","family":"Park","sequence":"additional","affiliation":[{"name":"Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1214-3856","authenticated-orcid":false,"given":"Andreas","family":"Rimner","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2345-6900","authenticated-orcid":false,"given":"Valerie W.","family":"Rusch","sequence":"additional","affiliation":[{"name":"Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0294-8749","authenticated-orcid":false,"given":"Narek","family":"Shaverdian","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5041-3941","authenticated-orcid":false,"given":"Smita","family":"Sihag","sequence":"additional","affiliation":[{"name":"Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2597-7091","authenticated-orcid":false,"given":"Abraham J.","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Jones","sequence":"additional","affiliation":[{"name":"Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY"},{"name":"Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4150-8604","authenticated-orcid":false,"given":"Gaetano","family":"Rocco","sequence":"additional","affiliation":[{"name":"Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY"},{"name":"Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,10,1]]},"reference":[{"key":"R1-20260409","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/SLA.0000000000001708","article-title":"Long-term survival based on the surgical approach to lobectomy for clinical stage I nonsmall cell lung cancer: comparison of robotic, video-assisted thoracic surgery, and thoracotomy lobectomy","volume":"265","author":"Yang","year":"2017","journal-title":"Ann Surg"},{"key":"R2-20260409","doi-asserted-by":"crossref","first-page":"296","DOI":"10.21037\/jtd.2017.02.22","article-title":"Curative resection for lung cancer in octogenarians is justified","volume":"9","author":"Tutic-Horn","year":"2017","journal-title":"J Thorac Dis"},{"key":"R3-20260409","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S1470-2045(15)70168-3","article-title":"Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials","volume":"16","author":"Chang","year":"2015","journal-title":"Lancet Oncol"},{"key":"R4-20260409","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/S1470-2045(21)00401-0","article-title":"Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery","volume":"22","author":"Chang","year":"2021","journal-title":"Lancet Oncol"},{"key":"R5-20260409","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jtho.2023.10.002","article-title":"Prospective cohort study to compare long-term lung cancer-specific and all-cause survival of clinical early stage (T1a\u2013b; \u226420 mm) NSCLC treated by stereotactic body radiation therapy and surgery","volume":"19","author":"Henschke","year":"2023","journal-title":"J Thorac Oncol"},{"key":"R6-20260409","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jtcvs.2023.07.021","article-title":"Overall survival in low-comorbidity patients with stage I non\u2013small cell lung cancer who chose stereotactic body radiotherapy compared to surgery","volume":"167","author":"Udelsman","year":"2023","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R7-20260409","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.4143\/crt.2022.1581","article-title":"Sublobar resection versus stereotactic body radiation therapy for clinical stage I non\u2013small cell lung cancer: a study using data from the Korean Nationwide Lung Cancer Registry","volume":"55","author":"Yun","year":"2023","journal-title":"Cancer Res Treat"},{"key":"R8-20260409","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.lungcan.2020.07.009","article-title":"Analysis of pneumonitis and esophageal injury after stereotactic body radiation therapy for ultra-central lung tumors","volume":"147","author":"Wang","year":"2020","journal-title":"Lung Cancer"},{"key":"R9-20260409","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.lungcan.2022.03.010","article-title":"Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)","volume":"166","author":"Van der Weijst","year":"2022","journal-title":"Lung Cancer"},{"key":"R10-20260409","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jtcvs.2009.03.030","article-title":"Lobectomy by video-assisted thoracic surgery (VATS) versus thoracotomy for lung cancer","volume":"138","author":"Flores","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R11-20260409","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.athoracsur.2005.11.048","article-title":"Operative mortality and respiratory complications after lung resection for cancer: impact of chronic obstructive pulmonary disease and time trends","volume":"81","author":"Licker","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"R12-20260409","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.prro.2017.04.014","article-title":"Stereotactic body radiation therapy for early-stage non-small cell lung cancer: executive summary of an ASTRO evidence-based guideline","volume":"7","author":"Videtic","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"R13-20260409","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.jtcvs.2021.07.030","article-title":"Definition and assessment of high risk in patients considered for lobectomy for stage I non\u2013small cell lung cancer: the American Association for Thoracic Surgery expert panel consensus document","volume":"162","author":"Pennathur","year":"2021","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R14-20260409","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ejcts.2006.01.014","article-title":"Carbon monoxide lung diffusion capacity improves risk stratification in patients without airflow limitation: evidence for systematic measurement before lung resection","volume":"29","author":"Brunelli","year":"2006","journal-title":"Eur J Cardiothorac Surg"},{"key":"R15-20260409","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.athoracsur.2007.05.053","article-title":"Incidence and risk factors for lung injury after lung cancer resection","volume":"84","author":"Alam","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"R16-20260409","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamanetworkopen.2019.3545","article-title":"Development and evaluation of a new frailty index for older surgical patients with cancer","volume":"2","author":"Shahrokni","year":"2019","journal-title":"JAMA Netw Open"},{"key":"R17-20260409","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2471\/BLT.07.045120","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"85","author":"Von Elm","year":"2007","journal-title":"Bull World Health Organ"},{"key":"R18-20260409","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nm.4333","article-title":"Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients","volume":"23","author":"Zehir","year":"2017","journal-title":"Nat Med"},{"key":"R19-20260409","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0022-5223(19)40289-4","article-title":"Multiple primary lung cancers","volume":"70","author":"Martini","year":"1975","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R20-20260409","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1044\/0161-1461.2501.15","article-title":"Selection of preschool language tests","volume":"25","author":"Plante","year":"1994","journal-title":"Lang Speech Hear Serv Sch"},{"key":"R21-20260409","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1002\/cncr.35286","article-title":"Longitudinal quality of life after sublobar resection and stereotactic body radiation therapy for early-stage non\u2013small cell lung cancer","volume":"130","author":"Wisnivesky","year":"2024","journal-title":"Cancer"},{"key":"R22-20260409","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1080\/0284186X.2018.1481292","article-title":"Stereotactic body radiation therapy (SBRT) improves local control and overall survival compared to conventionally fractionated radiation for stage I non-small cell lung cancer (NSCLC)","volume":"57","author":"von Reibnitz","year":"2018","journal-title":"Acta Oncol (Madr)"},{"key":"R23-20260409","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/SLA.0000000000006343","article-title":"A new functional threshold for minimally invasive lobectomy","volume":"280","author":"Vanstraelen","year":"2024","journal-title":"Ann Surg"},{"key":"R24-20260409","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1245\/s10434-022-11584-3","article-title":"A randomized, phase III study of sublobar resection (SR) versus stereotactic ablative radiotherapy (SAbR) in high-risk patients with stage I non-small cell lung cancer (NSCLC)","volume":"29","author":"Teke","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"R25-20260409","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jtcvs.2017.02.065","article-title":"A national analysis of wedge resection versus stereotactic body radiation therapy for stage IA non\u2013small cell lung cancer","volume":"154","author":"Yerokun","year":"2017","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R26-20260409","doi-asserted-by":"crossref","first-page":"e205601","DOI":"10.1001\/jamasurg.2020.5601","article-title":"A genomic-pathologic annotated risk model to predict recurrence in early-stage lung adenocarcinoma","volume":"156","author":"Jones","year":"2021","journal-title":"JAMA Surg"},{"key":"R27-20260409","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/JTO.0b013e31824165d7","article-title":"Is there a lower limit of pretreatment pulmonary function for safe and effective stereotactic body radiotherapy for early-stage non-small cell lung cancer?","volume":"7","author":"Guckenberger","year":"2012","journal-title":"J Thorac Oncol"},{"key":"R28-20260409","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.21037\/jtd-21-1825","article-title":"A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 3: systematic review of evidence regarding surgery in compromised patients or specific tumors","volume":"14","author":"Bade","year":"2022","journal-title":"J Thorac Dis"},{"key":"R29-20260409","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jvir.2021.02.025","article-title":"Effectiveness of Thermal ablation and stereotactic radiotherapy based on stage I lung cancer histology","volume":"32","author":"Uhlig","year":"2021","journal-title":"J Vasc Interv Radiol"},{"key":"R30-20260409","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jvir.2022.04.019","article-title":"Microwave ablation versus stereotactic body radiotherapy for stage I non\u2013small cell lung cancer: a cost-effectiveness analysis","volume":"33","author":"Wu","year":"2022","journal-title":"J Vasc Interv Radiol"},{"key":"R31-20260409","doi-asserted-by":"crossref","first-page":"e231988","DOI":"10.1148\/radiol.231988","article-title":"A 20-year follow-up of the International Early Lung Cancer Action Program (I-ELCAP)","volume":"309","author":"Henschke","year":"2023","journal-title":"Radiology"},{"key":"R32-20260409","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.jtcvs.2013.11.057","article-title":"Analysis of first recurrence and survival in patients with stage I non-small cell lung cancer treated with surgical resection or stereotactic radiation therapy","volume":"147","author":"Crabtree","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R33-20260409","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/j.jtho.2016.06.031","article-title":"Anatomical segmentectomy and wedge resections are associated with comparable outcomes for patients with small cT1N0 non-small cell lung cancer","volume":"11","author":"Altorki","year":"2016","journal-title":"J Thorac Oncol"},{"key":"R34-20260409","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/SLA.0000000000005115","article-title":"Pulmonary Open, Robotic and Thoracoscopic Lobectomy (PORTaL) Study","volume":"277","author":"Kent","year":"2021","journal-title":"Ann Surg"},{"key":"R35-20260409","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S1470-2045(12)70242-5","article-title":"Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis","volume":"13","author":"Senthi","year":"2012","journal-title":"Lancet Oncol"},{"key":"R36-20260409","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cllc.2015.09.006","article-title":"Recurrence patterns and second primary lung cancers after stereotactic body radiation therapy for early-stage non-small-cell lung cancer: implications for surveillance","volume":"17","author":"Spratt","year":"2016","journal-title":"Clin Lung Cancer"},{"key":"R37-20260409","doi-asserted-by":"crossref","first-page":"e166S","DOI":"10.1378\/chest.12-2395","article-title":"Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Brunelli","year":"2013","journal-title":"Chest"},{"key":"R38-20260409","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/ejcts\/ezab028","article-title":"Morbidity and mortality of lung resection candidates defined by the American College of Chest Physicians as \u201cmoderate risk\u201d: an analysis from the European Society of Thoracic Surgeons database","volume":"60","author":"Gooseman","year":"2021","journal-title":"Eur J Cardio-thoracic Surg"},{"key":"R39-20260409","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jtcvs.2014.03.007","article-title":"Thoracoscopic lobectomy is associated with acceptable morbidity and mortality in patients with predicted postoperative forced expiratory volume in 1 second or diffusing capacity for carbon monoxide less than 40% of normal","volume":"148","author":"Burt","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R40-20260409","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.lungcan.2018.09.020","article-title":"Stereotactic body radiation therapy versus sublobar resection for stage I NSCLC","volume":"125","author":"Ackerson","year":"2018","journal-title":"Lung Cancer"},{"key":"R41-20260409","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.ijrobp.2009.07.1751","article-title":"Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: Can SBRT be comparable to surgery?","volume":"81","author":"Onishi","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R42-20260409","first-page":"167","article-title":"Treatment of stage I lung cancer in high-risk and inoperable patients: SBRT vs. RFA vs. sublobar resection","volume":"3","author":"Bott","year":"2014","journal-title":"Ann Cardiothorac Surg"},{"key":"R43-20260409","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijrobp.2018.11.028","article-title":"Organs at risk considerations for thoracic stereotactic body radiation therapy: what is safe for lung parenchyma?","volume":"110","author":"Kong","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R44-20260409","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.ijrobp.2016.03.024","article-title":"Simple factors associated with radiation-induced lung toxicity after stereotactic body radiation therapy of the thorax: a pooled analysis of 88 studies","volume":"95","author":"Zhao","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R45-20260409","first-page":"63","article-title":"Safety and efficacy of stereotactic body proton therapy for high-risk lung tumors","volume":"9","author":"McMillan","year":"2023","journal-title":"J Radiosurg SBRT"},{"key":"R46-20260409","doi-asserted-by":"crossref","first-page":"101284","DOI":"10.1016\/j.adro.2023.101284","article-title":"Clinical and dosimetric risk factors associated with radiation-induced lung toxicities after multiple courses of lung stereotactic body radiation therapy","volume":"9","author":"Li","year":"2024","journal-title":"Adv Radiat Oncol"}],"container-title":["Annals of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SLA.0000000000006552","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T04:00:54Z","timestamp":1775707254000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/SLA.0000000000006552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/sla.0000000000006552","relation":{},"ISSN":["0003-4932","1528-1140"],"issn-type":[{"value":"0003-4932","type":"print"},{"value":"1528-1140","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,1]]}}}